Creation of the new biomedical research consortium: BioPol
The Autonomous Government of Catalonia, the City Council of L'Hospitalet de Llobregat, the University of Barcelona and the Bioregion of Catalonia (BioCat) yesterday formed the consortium that will manage the BioPol project. This new cluster of biological research will be based in L'Hospitalet, where the Barcelona Science Park will also be present. The aim of the consortium is to foster biomedical research in Catalonia and to form a basis for the creation of new businesses. At the same time, it aims to attract other companies in the pharmaceutical and biotechnology industry from outside Catalonia.
This project will include the participation of public-health institutions, research centers and firms from the areas of the life and social sciences. The participants will physically occupy the space formed by: the Bellvitge Institute for Biomedical Research (IDIBELL); the Catalan Institute of Bioengineering (IBEC); Bellvitge Hospital; The Catalan Institute of Oncology (ICO); the Bellvitge Campus of Health Sciences at the University of Barcelona; and the future Health Science Park BioPol. This last site, which is in l’Hospitalet de Llobregat, will be home to the firms that are joining this project.
The formal constitution of the consortium was presided over by the President of the Autonomous Government of Catalonia, José Montilla, and the Minister of Science and Innovation, Cristina Garmendia. The ceremony was also attended by the acting Rector of Barcelona University, Dr Josep Samitier; the director of Public Health, Marina Geli; the Mayor of l’Hospitalet de Llobregat, Núria Marín; and the Catalan Commissioner for Universities and Research, Blanca Palmada.